CTRI/2010/091/000068
Completed
Phase 3
To assess the Efficacy and Safety of Oral Budesonide-MMX 9mg Extended - release Tablets in patients with mild to moderate active ulcerative colitis,who fail to achieve clinical remission in study CB-01-02/01(parent study)
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Ulcerative Colitis
- Sponsor
- COSMO Technologies Ltd
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Males and females aged between 18 and 75 years of age, who are able to understand \& provide written informed consent.
- •Completed all final visit assessments for study CB\-01\-02/01 and are not in clinical remission.
- •Diagnosis of Ulcerative colitis of mild to moderate severity with Ulcerative Colitis Disease Activity Index less than or equal to 10 according to Sutherland.
- •Females of child\-bearing potential must have a serum pregnancy test performed at the final visit of the parent study and must use an acceptable contraceptive method thoughout the treatment period.
- •Ability to comprehend the full nature and purpose of the study,including possible risks and side effects.
- •Ability to co\-operate with the investigator and to comply with the requirements of the entire study.
Exclusion Criteria
- •Did not complete study CB\-01\-02/01
- •Achieved clinical remission in study CB\-01\-02/01
- •Patients with severe ulcerative colitis (UCDAI \> 10\), infectious colitis, evidence or history of toxic megacolon, severe anemia, leucopenia or granulocytopenia
- •Use of immunosuppressive agents in the last 8 weeks before study,use of anti\-tumour necrosis factor alpha agents in the last 3 months
- •Concomitant use of any rectal preparation for the treatment of ulcerative colitis,antibiotics
- •Concurrent use of CYP3A4 inducers and CYP3A4 inhibitors
- •Patients with verified,presumed or expected pregnancy or ongoing lactation,liver cirrhosis, or evident hepatic or renal disease or insufficiency, and/or severe impairment of the bio\-humoral parameters,severe disease(s) in other organs or systems,local or systemic complications or pathological states requiring a therapy with corticisteroids and/or immunosuppressive agents.
- •Patients diagnosed with type 1 diabetes, glaucoma, Hepatitis B, Hepatitis C, HIV acording to the local privacy policy.
- •Any other medical condition that in the principal investigator's opinion would make the administration of the study or study procedures hazardous to the subject or obscure the interpretation of adverse events.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 3
Investigation of Safety and Efficacy of Budesonide Inhalation Suspension in the Long-Term Use in Japanese Children With Bronchial Asthma (Open Long-Term Extension Study Following Study SD-004-0765AsthmaJPRN-jRCT2080220398AstraZeneca
Completed
Phase 4
The evaluation of the efficacy and safety of oral fingolimod in relapsing remitting multiple sclerosismultiple sclerosis.Disseminated Multiple SclerosisIRCT201406018323N10Vice-chancellor for research, Kermanshah University of Medical Sciences60
Active, Not Recruiting
N/A
Study to assess the efficacy and safety of oral potassium citrate on the Prevention of nephrocalcinosis in extreme premature. Study PRENECAincidence of nephrocalcinosis in extremely preterm infantsMedDRA version: 14.1Level: PTClassification code 10029146Term: NephrocalcinosisSystem Organ Class: 10038359 - Renal and urinary disordersTherapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]EUCTR2012-000298-22-ESFundació Clínic per a la Recerca Biomèdica
Recruiting
Phase 2
Safety and efficacy of Budesonide administration after endoscopic balloon dilation for Crohn's disease patients with intestinal stenosisCrohn's diseaseJPRN-jRCT1051190043Takehara Tetsuo15
Completed
N/A
Safety and efficacy of Budesonide administration after endoscopic ballon dilation for Crohn disease patients with intestinal stenosisCrohn's diseaseJPRN-UMIN000031839Osaka University Graduate School of Medicine Department of Gastroenterology and Hepatology17